Argenica Therapeutics (ASX:AGN) has achieved another important step in the progression of its Phase 2 trial to assess drug ...

Over the last two decades, ischemic stroke mortality rates in the U.S. have grown, with almost 3 in 10 deaths occurring at home, and increases particularly among racial minorities and rural residents.

A new USC-led study using functional magnetic resonance imaging (fMRI) reveals the neural mechanisms that contribute to ...

Stroke has long been viewed as a risk for just the older population. Now research is showing a concerning new trend.

A new USC-led study using functional magnetic resonance imaging (fMRI) reveals the neural mechanisms that contribute to ...

The American Academy of Neurology (AAN), the world’s largest association of neurologists and neuroscience professionals, has elected Natalia S. Rost, MD, MPH, FAAN, FAHA, as its 39th president. Rost ...

Richie Faulkner, a guitarist for legendary metal rock band Judas Priest, revealed he has permanent brain damage from a stroke he suffered in 2022. Faulkner, 45, suffered an acute cardiac aortic ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

A new study described testing the device on a 47-year-old woman with quadriplegia who couldn’t speak for 18 years after a ...

The Bio-Hermes Biomarker Data Challenge, was an international research competition launched in February of 2024 by the Brain ... Stroke Medicine at the University of Glasgow. Teams showcased their ...

Stroke is an important public health priority and is one of the leading causes of death and disability globally (GBD 2021 Stroke Risk Factor Collaborators, 2024). Increasingly, recent research has ...

(grant W2411067), the NSFC General Program (grant 82171267), the Genomics Platform Construction for Chinese Major Brain Disease-AVM (grant PXM2019_026280_000002-AVM), the Beijing Advanced Innovation ...